Expression Therapeutics

Expression Therapeutics

GA - Tucker
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Gene Therapies

Expression Therapeutics is a life sciences company focused on Gene Therapies.

ImmunologyRare DiseasesGastroenterology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT03016260RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
N/A
Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab
Rheumatoid Arthritis
N/A
Clinical Trials (1)
NCT01299545Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy
N/A
Gene therapy
Hemophilia A
Phase 1
Clinical Trials (1)
NCT04418414Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
Phase 1
Gradual immunosuppression drug withdrawal
Liver Transplantation
Phase 2
Clinical Trials (1)
NCT00647283Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 4 clinical trials
H-1B (2023): 1 approval

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub